Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep374 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Atherogenic Index of Plasma Associated Cardiovascular Risk in 10,241 Paediatric Patients

Ali Tomader , Helal Radwa , Khaled Rayan , Sabbour Hani , Lessan Nader

Background: Cardiovascular disease (CVD) is a leading cause of mortality. Childhood obesity is a major contributor to CVD. Atherogenic index of plasma (AIP) is an indicator of risk of atherosclerotic CVD. Associations between childhood obesity and CVD risk in the region remains under-explored. We aim to investigate this association as a predictor of CVD in this young population.Methods: Patients who attended our Centre (2009-2019), age ≤19 years an...

ea0090ep375 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Statin Treatment in Children and Adolescents with Elevated LDL-c in Patient with Normoglycaemia and Dysglycaemia

Helal Radwa , Ali Tomader , Khaled Rayan , Lessan Nader

Background: The obesity prevalence surge in children and adolescents is associated with dysglycaemia, dyslipidaemia and long-term cardiovascular complications. Use of lipid-lowering medications1 has been recommended following lifestyle modifications. We aim to investigate the demographic, and changes in LDL-c, in these young patients, in the presence and absence of dysglycaemia.Methods: Complete lipid profiles of patients (≤19 years old)...

ea0073aep161 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

An analysis of flash glucose monitoring (FGM) data on insulin-treated patients with diabetes: Effects of COVID-19 lockdown

Ashraf Tanveer , Helal Radwa , Majeed Maria , Lessan Nader

IntroductionFollowing the WHO declaration of COVID-19 as a pandemic and as many countries around the world, the United Arab Emirates government introduced gradual measures to stop the spread of the virus placing the country in a state of almost complete-lockdown. We report the impact of these restrictions on glucose control in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) on insulin therapy.Methods<p class="abst...

ea0070ep143 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Lipoatrophy in a patient with type 1 diabetes: Genetic or immunological?

Ashraf Tanveer , Awad Nisreen , Suliman Sara , Helal Radwa , Naqvi Safdar , Lessan Nader

We report the case of a 28-year-old Emirati lady with type 1 diabetes (weight 51 kg, BMI 20.82 kg/m2) diagnosed at 3 years of age who presented to our centre with problems at her insulin injection sites. She had poor glycaemic control and her diabetes was complicated by retinopathy; other past medical history included vitamin D deficiency. All her seven siblings had diabetes and were on insulin; both parents had type 2 diabetes.In 2017, she wa...